The US regulator has cleared Natural Cycles, the first direct-to-consumer smart phone application as a form of “digital contraception” despite a number of alarms raised by its users.
The US regulator has approved a drug to treat low potassium as the first generic with the Competitive Generic Therapy (CGT) designation, marking the beginning of a new strategy and FDA effo
The US drug regulator has approved Mulpleta (lusutrombopag) as a treatment for thrombocytopenia in certain patients with chronic liver disease who are about to undergo a medical procedure.<